{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:01:31Z","timestamp":1793109691381,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital \u2013 Instituto de Salud Carlos III","award":["FIS PI20\/00141"],"award-info":[{"award-number":["FIS PI20\/00141"]}]},{"name":"Fondo Europeo de Desarrollo Regional \u2013 FEDER"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Individuals with clinically suspect arthralgia (CSA, EULAR definition) are at increased risk of developing rheumatoid arthritis (RA) and early therapeutic intervention may delay or prevent progression. However, improved identification of likely progressors is needed to avoid unnecessary treatment. CD4+CXCR5+PD-1hi follicular helper (Tfh) and CD4+CXCR5-PD-1hi peripheral helper (Tph) T cells are implicated in RA pathogenesis. Notably, Tfh associate with favourable responses to co-stimulation blockade. Profiling these subsets in CSA could enhance our understanding of the RA preclinical phase, help identify progressors and select targeted therapies. Our objective was to assess circulating Tfh (cTfh) and Tph (cTph) cell frequencies in CSA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective, non-interventional study, peripheral blood was collected at baseline from CSA patients and age- and gender-matched healthy controls (HC). PBMCs were isolated and analysed by flow cytometry. Patients were followed until RA onset or for up to 48\u2009months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with HC, seropositive CSA (RF and\/or ACPA+, n\u2009=\u200933), but not seronegative CSA patients (n\u2009=\u200937), demonstrated expanded frequencies of cTfh and cTph cells. Among seropositive CSA patients, those who progressed to RA had higher baseline cTfh and cTph frequencies than non-progressors. A cTfh frequency &amp;gt;0.66% predicted progression (sensitivity 72%, specificity 85%). At RA onset, seropositive progressors (n\u2009=\u200919) showed a further increase in cTph, but not cTfh, frequency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Seropositive CSA patients display elevated baseline cTfh and cTph frequencies. Higher cTfh proportions associate with progression to RA. These findings support the use of cTfh and cTph profiling to stratify progression risk and guide early therapeutic decisions in at-risk individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf648","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T13:17:06Z","timestamp":1764767826000},"source":"Crossref","is-referenced-by-count":2,"title":["Expanded blood PD-1hi Tfh cells in seropositive clinically suspect arthralgia predict progression to rheumatoid arthritis"],"prefix":"10.1093","volume":"65","author":[{"given":"Laura","family":"Nu\u00f1o","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Hospital La Paz , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Nieto-Carvalhal","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital La Paz , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Guti\u00e9rrez-Riart","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital La Paz , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2200-0859","authenticated-orcid":false,"given":"Marta","family":"Novella-Navarro","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital La Paz , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Peiteado","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital La Paz , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3252-8016","authenticated-orcid":false,"given":"Irene","family":"Monjo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital La Paz , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Villalba","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital La Paz , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5146-1964","authenticated-orcid":false,"given":"Eugenio","family":"de Miguel","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital La Paz , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2334-4733","authenticated-orcid":false,"given":"Mar\u00eda-Eugenia","family":"Miranda-Car\u00fas","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital La Paz , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"2026022606033091600_keaf648-B1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"2026022606033091600_keaf648-B2","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.immuni.2022.11.009","article-title":"The pathogenesis of rheumatoid arthritis","volume":"55","author":"Alivernini","year":"2022","journal-title":"Immunity"},{"key":"2026022606033091600_keaf648-B3","doi-asserted-by":"publisher","first-page":"e005778","DOI":"10.1136\/rmdopen-2025-005778","article-title":"Windows for intervention in the prearthritis phase of rheumatoid arthritis? A narrative review of key triggering events and potential preventive strategies","volume":"11","author":"Kastbom","year":"2025","journal-title":"RMD Open"},{"key":"2026022606033091600_keaf648-B4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/annrheumdis-2016-209846","article-title":"EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis","volume":"76","author":"van Steenbergen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026022606033091600_keaf648-B5","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.1038\/s41467-023-43091-8","article-title":"Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritis","volume":"14","author":"James","year":"2023","journal-title":"Nat Commun"},{"key":"2026022606033091600_keaf648-B6","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/rheumatology\/kead466","article-title":"Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals","volume":"63","author":"Anioke","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606033091600_keaf648-B7","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1093\/rheumatology\/keae383","article-title":"A predictive model for progression to clinical arthritis in at-risk individuals with arthralgia based on lymphocyte subsets and ACPA","volume":"63","author":"Prajzlerov\u00e1","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606033091600_keaf648-B8","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1136\/annrheumdis-2015-207991","article-title":"T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals","volume":"75","author":"Hunt","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2026022606033091600_keaf648-B9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13075-016-1102-2","article-title":"Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients","volume":"18","author":"L\u00fcbbers","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2026022606033091600_keaf648-B10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/cells11071104","article-title":"Increased frequency of CD4+ follicular helper T and CD8+ follicular T cells in human lymph node biopsies during the earliest stages of rheumatoid arthritis","volume":"11","author":"Anang","year":"2022","journal-title":"Cells"},{"key":"2026022606033091600_keaf648-B11","doi-asserted-by":"publisher","first-page":"e004510","DOI":"10.1136\/rmdopen-2024-004510","article-title":"Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritis","volume":"10","author":"Turcinov","year":"2024","journal-title":"RMD Open"},{"key":"2026022606033091600_keaf648-B12","doi-asserted-by":"publisher","first-page":"e185217","DOI":"10.1172\/JCI185217","article-title":"Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis","volume":"135","author":"Inamo","year":"2025","journal-title":"J Clin Invest"},{"key":"2026022606033091600_keaf648-B13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/art.42839","article-title":"Expansion of HLA-DR positive peripheral helper T and naive B cells in anticitrullinated protein antibody-positive individuals at risk for rheumatoid arthritis","volume":"76","author":"Takada","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026022606033091600_keaf648-B14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41577-022-00693-5","article-title":"The link between circulating follicular helper T cells and autoimmunity","volume":"22","author":"Walker","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"2026022606033091600_keaf648-B15","doi-asserted-by":"publisher","first-page":"102539","DOI":"10.1016\/j.coi.2025.102539","article-title":"T cell-B cell interactions in human autoimmune diseases","volume":"93","author":"Sowerby","year":"2025","journal-title":"Curr Opin Immunol"},{"key":"2026022606033091600_keaf648-B16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"2026022606033091600_keaf648-B17","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/rheumatology\/kez169","article-title":"Two populations of circulating PD-1hiCD4 T cells with distinct B cell helping capacity are elevated in early rheumatoid arthritis","volume":"58","author":"Fortea-Gordo","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606033091600_keaf648-B18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/rheumatology\/keae090","article-title":"Circulating Tfh cells are differentially modified by abatacept or TNF blockers and predict treatment response in rheumatoid arthritis","volume":"64","author":"Monjo-Henry","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606033091600_keaf648-B19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/rheumatology\/kex012","article-title":"Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis","volume":"57","author":"Nakayamada","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606033091600_keaf648-B20","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/rheumatology\/keab454","article-title":"Blood PD-1+Tfh and CTLA-4+CD4+ T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis","volume":"61","author":"Aldridge","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606033091600_keaf648-B21","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2026022606033091600_keaf648-B22","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/rheumatology\/kex340","article-title":"The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia","volume":"56","author":"Ten Brinck","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606033091600_keaf648-B23","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.ard.2025.01.021","article-title":"EULAR\/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia","volume":"84","author":"van Steenbergen","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"2026022606033091600_keaf648-B24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrrheum.2017.185","article-title":"Preventing progression from arthralgia to arthritis: targeting the right patients","volume":"14","author":"van Steenbergen","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2026022606033091600_keaf648-B25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrrheum.2015.71","article-title":"Immune cell profiling to guide therapeutic decisions in rheumatic diseases","volume":"11","author":"Ermann","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"2026022606033091600_keaf648-B26","doi-asserted-by":"publisher","first-page":"689711","DOI":"10.3389\/fmed.2022.689711","article-title":"Disease mechanisms in preclinical rheumatoid arthritis: a narrative review","volume":"9","author":"Rom\u00e3o","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"suppl 9","key":"2026022606033091600_keaf648-B27","article-title":"Hydroxychloroquine does not prevent the future development of rheumatoid arthritis in a population with baseline high levels of antibodies to citrullinated protein antigens and absence of inflammatory arthritis: interim analysis of the StopRA trial [abstract]","volume":"74","author":"Deane","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026022606033091600_keaf648-B28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/ard.2008.105767","article-title":"Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2026022606033091600_keaf648-B29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","article-title":"Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"400","author":"Krijbolder","year":"2022","journal-title":"Lancet"},{"key":"2026022606033091600_keaf648-B30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2026022606033091600_keaf648-B31","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(23)02649-1","article-title":"Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial","volume":"403","author":"Cope","year":"2024","journal-title":"Lancet"},{"key":"2026022606033091600_keaf648-B32","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(23)02650-8","article-title":"Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial","volume":"403","author":"Rech","year":"2024","journal-title":"Lancet"},{"key":"2026022606033091600_keaf648-B33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/ard-2023-224211","article-title":"Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease","volume":"84","author":"Deane","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"2026022606033091600_keaf648-B34","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1084\/jem.190.8.1115","article-title":"Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXCR5-positive CD4 cells and germinal centers","volume":"190","author":"Walker","year":"1999","journal-title":"J Exp Med"},{"key":"2026022606033091600_keaf648-B35","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.immuni.2014.12.005","article-title":"The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells","volume":"41","author":"Sage","year":"2014","journal-title":"Immunity"},{"key":"2026022606033091600_keaf648-B36","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1073\/pnas.1414576112","article-title":"CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement","volume":"112","author":"Wang","year":"2015","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf648\/65760949\/keaf648.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/2\/keaf648\/65760949\/keaf648.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/2\/keaf648\/65760949\/keaf648.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:03:39Z","timestamp":1772103819000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keaf648\/8369095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf648","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,12,4]]},"article-number":"keaf648"}}